CMS’ new $50 billion rural health fund seeks to help rural providers sustain care in their communities over the next five ...

Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to ...

Phony bank account change requests aren’t just another check box on a fraud prevention list – they’re one of the most immediate and dangerous threats facing healthcare AP teams today.

The expiration of ACA tax credits could drive up premiums across marketplace and commercial insurance plans, a Cigna executive warned.

The Rural Health Transformation Program (RHTP) is more than a funding bill: It’s a $50 billion lifeline for rural hospitals on the brink of collapse, and time is running out to be positioned for ...

Providers increasingly accuse payers of delaying and denying reimbursement for claims. Now, UnitedHealth Group's Optum subsidiary is hoping to change the dynamic through what they claim is a real-time ...

Update: This case was resolved on Sunday evening via a settlement, so the trial never occurred. The attorneys representing Hernandez told MedCity News that he categorically denies the allegations.

Solera Health, a healthcare technology company, has raised $40 million in Series E financing to expand access to digital health support, the company announced on Tuesday. In addition, Interim CEO John ...

As always, this year's HLTH conference brought a slew of announcements — from product launches to funding rounds to new partnerships. This list features short summaries for seven of the conference’s ...

This week, five federal policy makers introduced legislation that would extend CMS’ waiver for hospital-at-home reimbursement by five years. Three representatives — Vern Buchanan (R-Florida), Lloyd ...

A rare liver disease that can progress to organ failure now has a new FDA-approved therapy, a drug from Ipsen that brings a novel approach to treating the chronic condition. The Ipsen drug, ...

Novo Nordisk is adding on to its cardiovascular drug pipeline with the acquisition of Cardior Pharmaceuticals, a genetic medicines developer whose lead program is in mid-stage clinical testing in ...